Refine Search
(1)
(1)
(2)
(4)

Diabetes Market

GlobalData's Competitive Landscape reports covering Type 1 and Type 2 diabetes provide an overview of these diseases and top-level epidemiology, pipeline assessment detailing late-stage products under development, clinical trials assessment, commercial assessment detailing key marketed products and current & future players and 10-year competitive landscape analysis (2016–2026) outlining critical events projected to occur in the 7MM and China. PharmaPoint and OpportunityAnalyzer reports offer in-depth market analyses and sales forecasts for Type 2 Diabetes and Diabetic Foot Ulcers in the 7MM.

Type 1 Diabetes: Competitive Landscape to 2026

  • $3,495
  • September 2018
Add to Basket Quick View Add to Saved List

Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which means that the body can no longer produce insulin. T1D can develop at any age, but is frequently observed in children and adolesc...

Type 2 Diabetes: Competitive Landscape to 2026

  • $3,495
  • March 2018
Add to Basket Quick View Add to Saved List

Type 2 Diabetes (T2D) is a chronic disease characterized by insulin resistance and pancreatic β-cell failure, with an underlying genetic predisposition heavily influenced by diet and lifestyle. Insulin is a hormone that regulates the glucose le...

PharmaPoint: Type 2 Diabetes – Global Drug Forecast and Market Analysis to 2026

  • $10,995
  • July 2017
Add to Basket Quick View Add to Saved List

While the global T2D market is crowded with inexpensive generics and marked by a pipeline filled with me-too drugs, GlobalData expects this market to undergo substantial growth between 2016 and 2026, doubling over the forecast period. The main ...

Opportunity Analyzer: Diabetic Foot Ulcers – Opportunity Analysis and Forecast to 2025

  • $10,995
  • December 2016
Add to Basket Quick View Add to Saved List

GlobalData estimates sales of diabetic foot ulcer (DFU) and diabetic foot infection (DFI) drugs to be approximately $292.1M across the 7MM in 2015, encompassing the US, 5EU, and Japan. DFU sales alone accounting for $118.7M across the 7MM. The ...